Javascript must be enabled to continue!
Decoding m6Am by simultaneous transcription-start mapping and methylation quantification
View through CrossRef
Abstract
N6,2’-O-dimethyladenosine (m6Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiological processes. m6Am mapping methods assume each gene uses a single start nucleotide. However, gene transcription usually involves multiple start sites, generating numerous 5’ isoforms. Thus, gene levels annotations cannot capture the diversity of m6Am modification in the transcriptome. Here we describe CROWN-seq, which simultaneously identifies transcription-start nucleotides and quantifies m6Am stoichiometry for each 5’ isoform that initiates with adenosine. Using CROWN-seq, we map the m6Am landscape in nine human cell lines. Our findings reveal that m6Am is nearly always a high stoichiometry modification, with only a small subset of cellular mRNAs showing lower m6Am stoichiometry. We find that m6Am is associated with increased transcript expression and provide evidence that m6Am may be linked to transcription initiation associated with specific promoter sequences and initiation mechanisms. These data suggest a potential new function for m6Am in influencing transcription initiation.
Title: Decoding m6Am by simultaneous transcription-start mapping and methylation quantification
Description:
Abstract
N6,2’-O-dimethyladenosine (m6Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiological processes.
m6Am mapping methods assume each gene uses a single start nucleotide.
However, gene transcription usually involves multiple start sites, generating numerous 5’ isoforms.
Thus, gene levels annotations cannot capture the diversity of m6Am modification in the transcriptome.
Here we describe CROWN-seq, which simultaneously identifies transcription-start nucleotides and quantifies m6Am stoichiometry for each 5’ isoform that initiates with adenosine.
Using CROWN-seq, we map the m6Am landscape in nine human cell lines.
Our findings reveal that m6Am is nearly always a high stoichiometry modification, with only a small subset of cellular mRNAs showing lower m6Am stoichiometry.
We find that m6Am is associated with increased transcript expression and provide evidence that m6Am may be linked to transcription initiation associated with specific promoter sequences and initiation mechanisms.
These data suggest a potential new function for m6Am in influencing transcription initiation.
Related Results
METTL4 catalyzes m6Am methylation in U2 snRNA to regulate pre-mRNA splicing
METTL4 catalyzes m6Am methylation in U2 snRNA to regulate pre-mRNA splicing
AbstractN 6-methylation of 2′-O-methyladenosine (Am) in RNA occurs in eukaryotic cells to generate N6,2′-O-dimethyladenosine (m6Am). Identification of the methyltransferase respons...
METTL4 catalyzes m6Am methylation inU2 snRNAto regulate pre-mRNA splicing
METTL4 catalyzes m6Am methylation inU2 snRNAto regulate pre-mRNA splicing
AbstractN6-methylation of 2’-O-methyladenosine (Am) in RNA occurs in eukaryotic cells to generateN6,2’-O-dimethyladenosine (m6Am). Identification of the methyltransferase responsib...
m6Am methyltransferase PCIF1 is essential for aggressiveness of gastric cancer cells by inhibiting TM9SF1 mRNA translation
m6Am methyltransferase PCIF1 is essential for aggressiveness of gastric cancer cells by inhibiting TM9SF1 mRNA translation
AbstractPCIF1 (phosphorylated CTD interacting factor 1) is the first reported RNA N6,2′-O-dimethyladenosine (m6Am) methyltransferase. However, the pathological significance of PCIF...
Abstract A37: Aberrant DNA methylation of HTATIP2 and UCH-L1 as prognostic and predictive biomarkers for cholangiocarcinoma
Abstract A37: Aberrant DNA methylation of HTATIP2 and UCH-L1 as prognostic and predictive biomarkers for cholangiocarcinoma
Abstract
Cholangiocarcinoma (CCA) is a malignancy of bile duct epithelial cell lining. In the past decade, the incidence and mortality rates of CCA have been increas...
Methylation of the RIZ1 Gene In Myelodysplastic Syndrome and Acute Myeloid Leukemia
Methylation of the RIZ1 Gene In Myelodysplastic Syndrome and Acute Myeloid Leukemia
Abstract
Abstract 5112
Inactivation of a tumor suppressor gene is often caused by a mutation, small deletion of one allele accompanied by loss of the ...
High Throughput Methylation Arrays Allow for Identification of Complex Methylation Patterns in MDS.
High Throughput Methylation Arrays Allow for Identification of Complex Methylation Patterns in MDS.
Abstract
Genomic imprinting and epigenetic silencing determine tissue-specific methylation patterns. Altered methylation of CpG islands within gene promoters has bee...
Correcting Methylation Calls in Clinically Relevant Low-Mappability Regions
Correcting Methylation Calls in Clinically Relevant Low-Mappability Regions
AbstractDNA methylation is an important component in vital biological functions such as embryonic development, carcinogenesis, and heritable regulation. Accurate methods to assess ...
Genome-Wide DNA Methylation Analysis Identifies Aberrant Epigenetic Changes in CD8+ T Cells from Chronic Lymphocytic Leukemia Patients
Genome-Wide DNA Methylation Analysis Identifies Aberrant Epigenetic Changes in CD8+ T Cells from Chronic Lymphocytic Leukemia Patients
Abstract
Background CD8+ T cells from chronic lymphocytic leukemia (CLL) patients have been demonstrated to exhibit a number of alterations in global gene expression...

